BioVie Insider Buying Surge Signals Confidence in Parkinson’s and Liver‑Cirrhosis Pipeline
BioVie’s insider option buying signals executive confidence in its Parkinson’s and liver‑cirrhosis pipeline, hinting at potential upside if FDA milestones are met.
4 minutes to read